Can I read Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls on EtoBox?

Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls by Shahrzad Mazhari; Neuroscience Research Centre, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.; Shokouh Arjmand; Mahin Eslami Shahrbabaki; Elham Karimi Ghoughari; Neuroscience Research Centre, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.; Department of Psychiatry, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.; Neuroscience Research Centre, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. is a Neuroscience article available to read on EtoBox.

What is Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls about?

## Introduction: The altered serum profiles of several trace elements have been reported in Schizophrenia (SCZ). This study was designed to elucidate whether the serum levels of Copper (Cu) and Magnesium (Mg), the two essential trace elements which contribute to neurotransmitter transmission, are altered in patients with SCZ. We also investigated whether there is an interrelation between cognitive functioning and the serum levels of Cu and Mg. ## Methods: Sixty patients with SCZ and 30 healthy controls participated in this study. The patient group was divided into the following: i) early patients (n=35, ≤5 years of illness initiation), and ii) chronic patients (n=25, ≥5 years of illness duration). The serum levels of Cu and Mg were measured by atomic absorption spectroscopy and ion-selective electrode potentiometry, respectively. To assess cognitive abilities, a Persian adaptation of the Brief Assessment of Cognition in Schizophrenia (BACS) was administered. ## Results: The present research results revealed significantly higher Cu serum levels in both patient groups [early patients (M=94.6), chronic patients (M=97.5)], compared to the controls (M=71.0) (P<0.001); however, no signif

Who reads Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls?

Author

Shahrzad Mazhari; Neuroscience Research Centre, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.; Shokouh Arjmand; Mahin Eslami Shahrbabaki; Elham Karimi Ghoughari; Neuroscience Research Centre, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.; Department of Psychiatry, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.; Neuroscience Research Centre, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Publisher

Negah Scientific Publisher

Published

2020

Language

EN

Field

Neuroscience (Life Sciences)